First documented case of intracranial falcine malignant peripheral nerve sheath tumor: illustrative case.
H3K27me3
intracranial malignant peripheral nerve sheath tumor
malignant intracerebral nerve sheath tumor
mesenchymal brain tumor
Journal
Journal of neurosurgery. Case lessons
ISSN: 2694-1902
Titre abrégé: J Neurosurg Case Lessons
Pays: United States
ID NLM: 9918227275606676
Informations de publication
Date de publication:
09 Aug 2021
09 Aug 2021
Historique:
received:
25
04
2021
accepted:
24
06
2021
entrez:
22
9
2022
pubmed:
23
9
2022
medline:
23
9
2022
Statut:
epublish
Résumé
The authors reported the first documented case of intracranial extraaxial nonneurofibromatosis type 1-related nontriton malignant peripheral nerve sheath tumor (MPNST) originating from the falx cerebri. A 34-year-old man with headache, short-term memory deficit, postural instability, and blurred vision presented with a large heterogenous contrast-enhanced intraventricular cystic lesion originating from the free margin of the falx cerebri. The patient received surgery using the right posterior interhemispheric approach. Gross total resection was performed, and the inferior border of the falx cerebri was resected. The postoperative course was uneventful. Histological examination revealed hypercellular foci of neoplastic spindle cells with hyperchromatic and wavy nuclei. Hence, a diagnosis of MPNST was made based on concomitant immunochemistry findings, including mouse double minute 2 homolog focal positivity and geographic loss of H3K27me3. The patient received adjuvant radiotherapy, and recurrence was not observed. Intracranial MPNSTs are extremely rare tumors, typically originating from the cranial nerves in the posterior cranial fossa. An even rarer variant of these tumors, referred to as malignant intracerebral nerve sheath tumors, may directly arise from the brain parenchyma. The authors reported the first case of an intracranial MPNST originating from the dura mater of the falx cerebri, acting as an extraaxial lesion with prevalent expansion in the right ventricle.
Sections du résumé
BACKGROUND
BACKGROUND
The authors reported the first documented case of intracranial extraaxial nonneurofibromatosis type 1-related nontriton malignant peripheral nerve sheath tumor (MPNST) originating from the falx cerebri.
OBSERVATIONS
METHODS
A 34-year-old man with headache, short-term memory deficit, postural instability, and blurred vision presented with a large heterogenous contrast-enhanced intraventricular cystic lesion originating from the free margin of the falx cerebri. The patient received surgery using the right posterior interhemispheric approach. Gross total resection was performed, and the inferior border of the falx cerebri was resected. The postoperative course was uneventful. Histological examination revealed hypercellular foci of neoplastic spindle cells with hyperchromatic and wavy nuclei. Hence, a diagnosis of MPNST was made based on concomitant immunochemistry findings, including mouse double minute 2 homolog focal positivity and geographic loss of H3K27me3. The patient received adjuvant radiotherapy, and recurrence was not observed.
LESSONS
CONCLUSIONS
Intracranial MPNSTs are extremely rare tumors, typically originating from the cranial nerves in the posterior cranial fossa. An even rarer variant of these tumors, referred to as malignant intracerebral nerve sheath tumors, may directly arise from the brain parenchyma. The authors reported the first case of an intracranial MPNST originating from the dura mater of the falx cerebri, acting as an extraaxial lesion with prevalent expansion in the right ventricle.
Identifiants
pubmed: 36131576
doi: 10.3171/CASE21255
pii: CASE21255
pmc: PMC9589474
doi:
pii:
Types de publication
Journal Article
Langues
eng
Références
Cancer. 2006 Sep 1;107(5):1065-74
pubmed: 16881077
J Neurooncol. 2011 Sep;104(2):605-10
pubmed: 21327709
Am J Surg Pathol. 2009 Mar;33(3):325-38
pubmed: 19065105
World Neurosurg. 2021 Jan;145:370-375
pubmed: 32861901
Neurol India. 2019 May-Jun;67(3):900-903
pubmed: 31347584
J Neurooncol. 2004 Jan;66(1-2):191-5
pubmed: 15015786
Onco Targets Ther. 2013 Apr 26;6:459-70
pubmed: 23667313
J Neurosurg. 1998 Sep;89(3):490
pubmed: 9724130
Asian J Neurosurg. 2019 Jul-Sep;14(3):922-926
pubmed: 31497130
Case Rep Surg. 2013;2013:384076
pubmed: 24191220
Neurosurgery. 2004 Feb;54(2):500-3; discussion 503-4
pubmed: 14744297
J Surg Oncol. 2012 Jul 1;106(1):51-6
pubmed: 22253011
Acta Neuropathol. 2016 Jun;131(6):877-87
pubmed: 26857854
World Neurosurg. 2013 Nov;80(5):654.e1-8
pubmed: 23022650
Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):351-60
pubmed: 9788415
J Clin Neurosci. 2007 Jun;14(6):589-92
pubmed: 17382548
Acta Neurol Belg. 2008 Jun;108(2):67-71
pubmed: 18795600
Am J Surg Pathol. 2020 Jul;44(7):922-933
pubmed: 32141887
Int J Surg Case Rep. 2016;29:196-200
pubmed: 27871009
Neurosurgery. 2008 Apr;62(4):825-32; discussion 832
pubmed: 18496188
World Neurosurg. 2012 Nov;78(5):505-10
pubmed: 22120554
J Neurosurg. 1995 Jan;82(1):121-4
pubmed: 7815115
Cancer Radiother. 2016 Apr;20(2):119-32
pubmed: 26934901
Auris Nasus Larynx. 2010 Oct;37(5):539-45
pubmed: 20399579
Acta Neurochir (Wien). 2017 Mar;159(3):403-418
pubmed: 28093610
Childs Nerv Syst. 2018 Aug;34(8):1605-1608
pubmed: 29616298
Acta Radiol. 2017 Oct;58(10):1222-1230
pubmed: 28068826
J Comput Assist Tomogr. 2020 Nov/Dec;44(6):928-940
pubmed: 33196600
Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1174-84
pubmed: 12128118
Neurosurgery. 2011 Apr;68(4):E1152-8; discussion E1159
pubmed: 21242836
Surg Neurol. 1993 Feb;39(2):128-32
pubmed: 8351625
Am J Surg Pathol. 2016 Apr;40(4):479-89
pubmed: 26645727
Anticancer Res. 2013 Jun;33(6):2597-604
pubmed: 23749914
Acta Neurochir (Wien). 2000;142(4):473-6; discussion 477
pubmed: 10883347